Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Arthritis Care Res (Hoboken) ; 64(12): 1787-93, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22730317

RÉSUMÉ

OBJECTIVE: To propose a common nomenclature to refer to individuals who fulfill the American College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) during childhood or adolescence. METHODS: The medical literature was reviewed for studies conducted in the target population between 1960 and December 2011 to obtain information about the terms used to refer to such children and adolescents. We reviewed the threshold ages used and disease features considered to discriminate these individuals from patients with onset of SLE during adulthood. Furthermore, the nomenclature used in other chronic diseases with onset during both childhood and adulthood was assessed. RESULTS: There was an astonishing variability in the age cutoffs used to define SLE onset prior to adulthood, ranging from 14-21 years, but most studies used age 18 years. The principal synonyms in the medical literature were SLE without reference to the age at onset of disease, childhood-onset SLE, juvenile SLE, and pediatric (or paediatric) SLE. CONCLUSION: Based on the definition of childhood, in analogy with other complex chronic diseases commencing prior to adulthood, and given the current absence of definite genetic variations that discriminate adults from children, the term childhood-onset SLE is proposed when referring to individuals with onset of SLE prior to age 18 years.


Sujet(s)
Lupus érythémateux disséminé/épidémiologie , Terminologie comme sujet , Adolescent , Répartition par âge , Âge de début , Enfant , Enfant d'âge préscolaire , Humains , Indice de gravité de la maladie
3.
J Pediatr ; 148(5): 683-6, 2006 May.
Article de Anglais | MEDLINE | ID: mdl-16737887

RÉSUMÉ

We describe 3 patients who presented with features of macrophage activation syndrome (MAS) at the time of presentation of systemic lupus erythematosus (SLE), systemic juvenile idiopathic arthritis, and Kawasaki disease. Immunohistochemical studies in the patient with SLE demonstrated extensive expression of CD163 on hemophagocytic macrophages, suggesting a possible role as a marker of MAS.


Sujet(s)
Arthrite juvénile/complications , Lupus érythémateux disséminé/complications , Activation des macrophages , Maladie de Kawasaki/complications , Adolescent , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/métabolisme , Arthrite juvénile/immunologie , Arthrite juvénile/métabolisme , Femelle , Humains , Nourrisson , Lupus érythémateux disséminé/immunologie , Lupus érythémateux disséminé/métabolisme , Mâle , Maladie de Kawasaki/immunologie , Maladie de Kawasaki/métabolisme , Récepteurs de surface cellulaire/métabolisme , Syndrome
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE